Monitoring the adverse reactions of COVID-19 vaccines

On January 27, 2021, Fimea opened a website for adverse reaction reports for coronavirus vaccines. The page is updated more than once a week by the number and severity of adverse reaction reports.


Great talents joining DRA

Get to know the experts of our growing team. Welcome to Outi, Jaana, Katariina ja Soile.


International cooperation in evaluating COVID-19 vaccines and drug therapies

EMA has launched a new OPEN pilot to increase international cooperation in evaluating COVID-19 vaccines and drug therapies. The project started in December 2020.


First notified body approved in Finland

Fimea has approved the first notified body under the new Medical Devices Regulation (MDR), SGS Fimko Oy, in Finland.


Our team of great colleagues has grown again

Pharmacist specialising in industrial pharmacy Linda Tossavainen-Nikki, MBA and B.Sc. (Pharm.), and pharmacist Anna-Kaisa Tuderman,  M.Sc. (Pharm), are joining our regulatory services team. Sami Tyrjy B.Sc. (Pharm.) has started as a new employee in our sales and marketing team.


Pharmacovigilance now and in the future – Current topics of the World Drug Safety Congress Europe

Future trends were emphasised strongly in the discussion, especially with regard to the development possibilities introduced by new technological solutions. Read the highlights of the event.


DRA takes part in the ISPOR Europe 2020 

DRA’s Market Access experts participate in the virtual ISPOR Europe 2020 conference. The theme of the four-day event is Improving Health: Establishing Incentives and Sharing Value.  The aim of the event is to find new perspectives with the global network of HEOR experts on how we establish and share value sustainable for health systems, patients, and technology developers. Virtual ISPOR Europe 2020 will […]


Growing business requires new kinds of experts

Outi Järvinen, has started work as Head of Resourcing and Accounts in DRA’s sales and marketing team.


DRA welcomes new professionals

Get to know the experts of our growing team. Welcome to Pia, Virpi, Heli, Stina, Vilhelmiina, Riina and all three Heidi.


Combining exercise, fun, and charity – Cycling Day on September 17th

This year we’ve support Finnish cancer research in co-operation with the Cancer Foundation Finland.


DRA takes part in the Nordic Regulatory Affairs seminar

The virtual event gathers Nordic authorities and actors within the pharmaceutical industry together to discuss current topics in their field.


Expert’s Voice – How to obtain over-the-counter status for a medicinal product Q&A

In this interview, our experienced marketing authorisation expert, will tell about the process and the questions that arise around it at application stage. 

1 2 3 4 5 15